Navidea Biopharmaceuticals, Inc. (NAVB)
OTCMKTS: NAVB · Delayed Price · USD
0.0440
+0.0065 (17.33%)
Apr 25, 2024, 9:30 AM EDT - Market open
NAVB Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1992 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.07 | 0.53 | 0.92 | 0.03 | 0.32 | 1.81 | 21.97 | 13.25 | 6.27 | 1.13 | Upgrade
|
| Revenue Growth (YoY) | -87.65% | -41.91% | 3337.57% | -91.75% | -82.19% | -91.76% | 65.82% | 111.15% | 454.99% | 1335.94% | Upgrade
|
| Cost of Revenue | 0.18 | 0 | 0 | 0.01 | 0.1 | 0 | 2.3 | 1.75 | 1.59 | 0.33 | Upgrade
|
| Gross Profit | -0.12 | 0.53 | 0.91 | 0.02 | 0.23 | 1.81 | 19.67 | 11.49 | 4.69 | 0.8 | Upgrade
|
| Selling, General & Admin | 7.96 | 7.45 | 6.69 | 6.28 | 7.7 | 11.17 | 13.01 | 17.26 | 15.54 | 15.53 | Upgrade
|
| Research & Development | 5.97 | 5.14 | 4.93 | 5.34 | 4.22 | 4.51 | 8.88 | 12.79 | 16.78 | 23.71 | Upgrade
|
| Other Operating Expenses | -0.03 | -0.01 | -0.02 | -0.63 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 13.93 | 12.59 | 11.63 | 10.98 | 11.07 | 15.68 | 21.9 | 30.05 | 32.32 | 39.24 | Upgrade
|
| Operating Income | -14.05 | -12.06 | -10.71 | -10.96 | -10.85 | -13.88 | -2.22 | -18.55 | -27.63 | -38.44 | Upgrade
|
| Interest Income | 0.33 | 0.01 | 0.01 | 0.03 | 0 | 0 | 0 | 0 | 0.02 | 0.02 | Upgrade
|
| Interest Expense | 1.1 | 0.01 | 0 | 0.03 | 0.03 | 0.17 | -14.86 | -6.87 | 3.71 | 2.78 | Upgrade
|
| Other Expense / Income | 0.35 | -0.35 | 0.02 | -0.02 | 5.25 | -84.93 | 27.59 | 16.32 | 1.72 | -0.87 | Upgrade
|
| Pretax Income | -15.18 | -11.71 | -10.72 | -10.94 | -16.17 | -17.79 | -14.31 | -28.76 | -35.73 | -42.7 | Upgrade
|
| Income Tax | 2.04 | 0.02 | -0.08 | 0 | 0 | -4.06 | -0.65 | -0.44 | 2.68 | 2.37 | Upgrade
|
| Net Income | -17.22 | -11.73 | -10.64 | -10.95 | -16.13 | 74.95 | -14.31 | -27.56 | -35.73 | -42.7 | Upgrade
|
| Shares Outstanding (Basic) | 29 | 29 | 24 | 14 | 9 | 8 | 8 | 8 | 7 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 29 | 24 | 14 | 9 | 8 | 8 | 8 | 7 | 6 | Upgrade
|
| Shares Change | - | 22.80% | 66.02% | 68.80% | 2.72% | 6.82% | 2.81% | 1.63% | 22.12% | 22.96% | Upgrade
|
| EPS (Basic) | -0.59 | -0.40 | -0.45 | -0.76 | -1.89 | 9.40 | -1.84 | -3.65 | -4.80 | -7.01 | Upgrade
|
| EPS (Diluted) | -0.59 | -0.40 | -0.45 | -0.76 | -1.89 | 9.00 | -1.84 | -3.65 | -4.80 | -7.01 | Upgrade
|
| Free Cash Flow | -9.38 | -10.55 | -8.59 | -9.41 | 4.23 | 59.05 | 3.55 | -19.14 | -30.32 | -36.9 | Upgrade
|
| Free Cash Flow Per Share | -0.32 | -0.36 | -0.36 | -0.65 | 0.50 | 7.11 | 0.46 | -2.53 | -4.08 | -6.06 | Upgrade
|
| Gross Margin | -181.71% | 100.00% | 99.89% | 74.95% | 70.04% | 99.80% | 89.54% | 86.76% | 74.72% | 70.56% | Upgrade
|
| Operating Margin | -21402.08% | -2269.07% | -1170.60% | -41184.60% | -3363.29% | -766.50% | -10.12% | -140.01% | -440.38% | -3399.73% | Upgrade
|
| Profit Margin | -26221.65% | -2207.08% | -1162.82% | -41120.85% | -5000.12% | 4139.67% | -65.13% | -208.03% | -569.36% | -3776.61% | Upgrade
|
| Free Cash Flow Margin | -14282.76% | -1984.44% | -938.53% | -35357.39% | 1311.31% | 3261.64% | 16.18% | -144.48% | -483.17% | -3264.06% | Upgrade
|
| EBITDA | -14.05 | -12.43 | -10.71 | -10.96 | -5.56 | -9.8 | -4.51 | -15.22 | -28.16 | -38.44 | Upgrade
|
| EBITDA Margin | -21402.08% | -2337.93% | -1170.60% | -41184.60% | -1722.58% | -541.05% | -20.54% | -114.85% | -448.72% | -3399.73% | Upgrade
|
| Depreciation & Amortization | 0.1 | 0.08 | 0.07 | 0.14 | 0.15 | 0.25 | 0.5 | 0.57 | 0.5 | 0.4 | Upgrade
|
| EBIT | -14.15 | -12.5 | -10.78 | -11.11 | -5.71 | -10.05 | -5.01 | -15.79 | -28.66 | -38.84 | Upgrade
|
| EBIT Margin | -21548.03% | -2352.41% | -1178.30% | -41727.51% | -1769.21% | -555.11% | -22.82% | -119.16% | -456.70% | -3435.47% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.